PPARA and glioblastoma: As HIF-1α is associated with poor prognosis in glioblastoma, targeting the HIF pathway is considered as an important therapeutic strategy.5–7 Interestingly, evidences suggest mutual inhibitory mechanisms between PPAR and HIF-1α.